Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 CAD | -5.13% |
|
0.00% | +5.71% |
Jun. 20 | Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy | CI |
Jun. 12 | Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy | CI |
Sales 2024 * | 1M 733K | Sales 2025 * | - | Capitalization | 46.66M 34.21M |
---|---|---|---|---|---|
Net income 2024 * | -4M -2.93M | Net income 2025 * | -4M -2.93M | EV / Sales 2024 * | 46.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-18.5
x | P/E ratio 2025 * |
-18.5
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.17% |
1 day | -5.13% | ||
Current month | -11.90% | ||
1 month | +32.14% | ||
3 months | +15.62% | ||
Current year | +5.71% |
![Extreme 0.185](/images/extremecours_fleche.png)
![Extreme 0.15](/images/extremecours_fleche.png)
![Extreme 0.14](/images/extremecours_fleche.png)
![Extreme 0.14](/images/extremecours_fleche.png)
![Extreme 0.14](/images/extremecours_fleche.png)
![Extreme 0.12](/images/extremecours_fleche.png)
![Extreme 0.12](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 89-08-21 | |
Kristina Hachey
DFI | Director of Finance/CFO | - | 19-06-26 |
Arkady Mandel
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 89-08-21 | |
Kristina Hachey
DFI | Director of Finance/CFO | - | 19-06-26 |
Randy Bruder
BRD | Director/Board Member | - | 07-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 0.185 | -5.13% | 101,810 |
24-07-02 | 0.195 | -7.14% | 49,600 |
24-06-28 | 0.21 | +10.53% | 147,417 |
24-06-27 | 0.19 | +2.70% | 61,202 |
24-06-26 | 0.185 | 0.00% | 48,000 |
Delayed Quote Toronto S.E., July 03, 2024 at 03:59 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.71% | 34.07M | |
-3.38% | 808M | |
-33.08% | 210M | |
0.00% | 108M | |
-34.78% | 79.84M | |
-2.90% | 52.56M |
- Stock Market
- Equities
- TLT Stock